Freshpet Raises 2026 Guidance as Fresh Pet Food Keeps Outrunning the Category

Pet food earnings season has mostly been an exercise in explaining slower store traffic and cautious spending. Freshpet delivered the opposite this week: second-quarter net sales up 15.5% to $305.6 million, adjusted EBITDA up nearly 18% to $52.2 million, and a raised full-year outlook that pushes its projected margin ceiling higher for 2027 too.

Freshpet lifts its full-year sales and margin targets

The quarter itself was clean. Net sales reached $305.6 million against $264.7 million a year earlier, and adjusted gross margin expanded to 48.6% from 46.9%. Net income rose to $19.5 million from $16.4 million, and adjusted EBITDA climbed to $52.2 million from $44.4 million. Through the first half of 2026, net sales are up 14.3% to $603.2 million and adjusted EBITDA is up to $90.1 million from $79.9 million.

Management used the quarter to raise guidance rather than simply reiterate it. Full-year net sales growth is now projected at 10% to 12%, up from 8% to 11% entering the quarter, and adjusted EBITDA guidance moved to $210 million to $220 million from $205 million to $215 million. The company also nudged its 2027 targets higher, putting adjusted gross margin at 49% or better and adjusted EBITDA margin at 20% to 22%.

CEO Billy Cyr framed it as consistency rather than a one-quarter pop, saying the results demonstrate "the strength and resilience of our business model" against a backdrop he described as an increasingly cautious consumer.

What the beat means for a slowing pet aisle

The context is what makes the number interesting. Retailers with heavy pet exposure have spent the summer describing a pet aisle that's dragging on results, not lifting them: Tractor Supply closed a third of its Petsense locations as its pet category weighed down the quarter, and general merchandise chains have flagged softer discretionary pet spending across the board. Freshpet's refrigerated case is, for now, running in the opposite direction.

That divergence is the story operators should sit with. Freshpet isn't competing for the same wallet as bagged kibble or discretionary pet accessories; the fresh, refrigerated format has been taking share inside a category that is otherwise flat to shrinking, and this quarter is more evidence that the substitution is real rather than a pandemic-era blip that fades. A 15.5% top-line gain in a consumer environment most retailers describe as cautious is not something inflation or price alone explains.

It also lands the same week as a second data point in the same direction. A day earlier, animal-health diagnostics leader IDEXX also beat and raised its 2026 outlook, the second time this year it has done so. Two different categories, two different customer bases, but the same underlying signal: parts of the pet economy tied to premiumization and owner spend on animal wellbeing are still expanding even as general pet retail, the side of the business Tractor Supply is now shrinking, pulls back. For operators building anywhere near fresh, therapeutic, or premium pet nutrition, that's a more useful data point than the headline growth number alone.

On the numbers themselves: Freshpet's new EBITDA range is up $5 million at the midpoint from where it started the quarter, a roughly 2.4% lift, while the sales-growth range moved further, with both ends raised and the low end alone climbing 200 basis points. That's the second beat-and-raise pet-sector earnings story The Underbite has covered in the past two days, a run rate worth tracking if it continues into the rest of earnings season.

What Zoetis's flat quarter says about the divide

The read-through has since arrived. Zoetis posted flat second-quarter revenue on August 6, its second soft quarter in a row. That's the selective-retrenchment scenario, not a blanket pullback: pet owners are still paying up for fresh food and diagnostics while pulling back on discretionary veterinary treatments, exactly the split Freshpet and IDEXX's results this week suggested.

Closer to home, Freshpet's own guidance now assumes roughly $150 million in capital spending this year while still generating positive free cash flow, a combination the company hasn't always managed cleanly in past expansion cycles. Whether that capex converts into the shelf space and production capacity needed to hit the raised 2027 margin targets, rather than getting absorbed by fresh manufacturing's historically thin tolerances, is the next checkpoint worth watching.

Source: Freshpet, Inc. Reports Second Quarter 2026 Financial Results via GlobeNewswire